Abstract. The aim of the present study was to investigate the association of human leukocyte antigen (HLA) gene polymorphism and clinical phenotypes of patients with mesangial proliferative glomerulonephritis (MsPGN). The genotyping of HLA-A, HLA-B and HLA-DRB1 alleles was detected in 1,536 consecutive MsPGN patients during the previous five years and 2,027 age-and gender-matched healthy individuals by using the polymerase chain reaction-sequence-specific primers method. The clinical and pathological data of the patients were collected and the genotype frequencies (GF) and odds ratio (OR) were analyzed. The allele frequencies of HLA-A*23, A*25, B*15, B*40, B*53 and DRB1*18 were significantly higher in MsPGN patients than in the controls (P<0.05). These alleles were considered as the suspected susceptibility genes (SSG) for MsPGN. Of note, results of the follow-up survey study demonstrated poorer prognosis of patients with SSG than those without SSG.
Introduction
The major histocompatibility complex (MHC) is located centromeric to human leukocyte antigen (HLA)-B and has >65 polymorphic alleles (IMGT/HLA database) (1) . Their genes span 3,600 kb DNA on chromosome 6 and encode a group of cell-surface antigen-presenting proteins. These proteins constitute the most complex dominant hereditary system associated with polymorphisms in human, and there were dominant diversities among different ethnicities and geographical regions. This gene has been associated with susceptibility to various autoimmune diseases (2) (3) (4) (5) (6) (7) (8) , including chronic glomerulonephritis (CGN) (9) , which is the leading primary disease resulting in renal failure and death. HLA gene polymorphism is associated with the incidence of CGN in China (10) . However, the majority of those results were based on small samples and were limited to specific populations or regions. Eastern China is the most populated region in China and has only 10,000 reported CGN patients. By contrast, mesangial proliferative glomerulonephritis (MsPGN) is the most common disease of CGN in China, however, an association between HLA polymorphism and MsPGN in this region has yet to be reported in a large population-based study. This epidemiological study therefore provided some basic information on the HLA genotypes of MsPGN patients in the eastern region of China. Its possible significance in the diagnosis and prognosis of CGN and in clarifying the mechanisms of the disease were also discussed. Statistical analysis. Allele frequency distributions were confirmed by calculating the frequencies of the genotypes HLA-A, HLA-B, and HLA-DRB1 as being in Hardy-Weinberg equilibrium using Arlequin v.3.1 software. Analyses related to the case-control study were performed using the Statistical Package for the Social Sciences v.16 (SPSS Inc., Chicago, IL, USA). Differences between MsPGN patients and the controls were analyzed using the χ 2 and Fisher's exact tests for qualitative variables and the t-test for quantitative variables. The odds ratio (OR) was calculated to evaluate the association between the alleles and the disease. The Bonferroni method was used to adjust for type I errors due to multiple comparisons. P<0.05 was considered to indicate a statistically significant difference. Table I summarizes the main clinical characteristics of the 1,536 unrelated MsPGN patients. The age at onset of disease was 13-75 years (mean, 35.62±13.5 years). The entire patient cohort had undergone a renal biopsy for an exact histological diagnosis. Follow-up survey. Forty-nine patients with SSG and 52 patients without SSG-carrying were randomly selected for follow-up, and a survival rate (SR) of 1, 3 and 5 years subsequent to kidney transplant was calculated. The results showed that the SR was 95.6%, 72.3 and 50.8% for SSG-carrying patients, and 98.4, 89.6 and 74.8% without SSG-carrying patients. Statistical differences were observed in SRs for patients with or without SSG according to results of the log-rank test (χ 2 =6.6783, P<0.01).
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Demographic characteristics of MsPGN patients.
Comparison of the HLA-
Discussion
Mesangial proliferation is a basic pathologic process of various kidney diseases. MsPGN is the common pathological type that progresses to end-stage renal failure, and is histologically characterized by a marked mesangial increase and expansion of extracellular matrix in the glomeruli (13,14) . The pathogenesis of MsPGN remains unclear, and genetic predisposition Table IV . Comparison of human leukocyte antigen-DRB1 genotype frequencies in mesangial proliferative glomerulonephritis (MsPGN) patients and controls.
Controls
MsPGN may be a risk factor. Recent studies (15) (16) (17) (18) have demonstrated that HLA alleles are associated with certain idiopathic renal diseases, including those detected in previous studies (19, 20) .
In the present study, we detected 23 alleles of HLA-A, 47 alleles of HLA-B and 14 alleles of HLA-DRB1 in 1,536 MsPGN patients in Eastern China. The results showed that the HLA-A*23, A*25, B*15, B*40, B*53 and DRB1*18 alleles were significantly higher in the MsPGN patients as compared to the HC. Results of the follow-up survey demonstrated these alleles to be SSG for MsPGN patients. However, the allele frequencies of A*32, A*33, B*50, B*58, B*60, B*71 and DRB1*16 were significantly lower in the MsPGN patients compared to the HC. This finding suggested that these alleles might be protective genes of MsPGN. Compared with ethnicities regions of China, our study proved that certain HLA alleles are potential hereditary risk factors for susceptibility to CGN (21, 22) . Thus, we observed that there were clear diversities of the highly polymorphic HLA system among ethnicities and regions. In addition, the alleles HLA-A*20, A*22, A*35, A*36, A*38, B*21, B*73 and B*78 were positive in rare cases of MsPGN (2, 3, 1, 1, 1, 1, 1 and 1 cases, respectively) although no alleles were identified to be positive in 2,027 HC. Their association with MsPGN remains to be clarified.
Previous studies have shown that HLA-DRB1, HLA-DQB1 and HLA-DPB1 alleles are associated with MsPGN disease anti-glomerular basement membrane disease (23) in Caucasian as well as Asian populations. The present study has proven that certain HLA alleles are potential hereditary risk factors for susceptibility to CGN. By contrast, we detected the GF of haplotypes A*30-B*13-DRB1*07, A* 0 2 -B * 1 3 -D R B1* 0 7, A* 3 3 -B * 4 4 -D R B1* 1 3 , A*02-B*46-DRB1*09 and A*33-B*58-DRB1*13, findings consistent with those identified in Northern China (23) . Previous reports (24) have identified the frequencies of haplotypes A*02-B*13-DRB1*07, A*33-B*44-DRB1*13, A*02-B*46-DRB1*09 and A*33-B*58-DRB1*13 to be high in Northern China, however, this was not the case in the present study. An analysis of the haplotypes revealed haplot y p es A*23 -B*4 4 -DR B1*18, A*25-B*15 -DR B1*07, A* 03 -B*70 -DR B1*11, A*68 -B*13 -DR B1* 0 4 a nd A*11-B*10-DRB1*12 to be significantly higher in MsPGN patients than the HC. An association of HLA polymorphism with the prognosis of MsPGN patients was also identified in this study. SRs of 1, 3 and 5 years for patients with SSGs (HLA-A*23, A*25, B*15, B*40, B*53 and DRB1*18) were lower than those of patients not carrying SSGs, and the difference was statistically significant.
In conclusion, in this large population-based study, we detected a strong association between HLA genotypes and MsPGN in Eastern China. Specific genotypes and haplotypes of HLA were closely associated with the incidence of common renal disorder and prognosis. The relationship may also be significant in revealing the immunological pathogenesis of CGN.
